Thursday, January 18, 2018

Evofem Biosciences Closes Merger With Neothetics

San Diego-based Evofem, which develops products in the area of women's sexual and reproductive health, has merged with Neothetics. As part of the merger, Evofem said it will begin trading on the NASDAQ Capital Market as EVFM. Evofem is led by CEO Saundra Pelletier. Invesco Asset Management Limited has invested $20M in stock of the merged company as part of the merger deal.

---